You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • FRI0118 Clinical utility of area-under-curve (AUC) of patient-derived disease activity score (PDAS2) between clinic visits on remission, flare up and rheumatologist's decision to escalate anti-rheumatic drugs

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
FRI0118 Clinical utility of area-under-curve (AUC) of patient-derived disease activity score (PDAS2) between clinic visits on remission, flare up and rheumatologist's decision to escalate anti-rheumatic drugs
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Leung M, Choy E, Lau C
FRI0118 Clinical utility of area-under-curve (AUC) of patient-derived disease activity score (PDAS2) between clinic visits on remission, flare up and rheumatologist's decision to escalate anti-rheumatic drugs
Annals of the Rheumatic Diseases 2017;76:525.